Versant Vantage I, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 260,034 shares at $33.01 ($8.6M) on 2020-11-19, disclosed to the SEC on 2020-11-23.
Scheduled sale ($8.6M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.01 | 15,163 | $501K | 5.8% |
| 2 | $33.01 | 15,163 | $501K | 5.8% |
| 3 | $33.01 | 114,854 | $3.8M | 44.2% |
| 4 | $33.01 | 114,854 | $3.8M | 44.2% |
| Total | $33.01 avg | 260,034 | $8.6M | 100% |
| Filing → |
| BDTX | SELL | 2020-11-12 | $2.6M | — | Filing → |
| BDTX | SELL | 2020-11-10 | $586K | — | Filing → |
| RPTX | BUY | 2020-06-25 | $5.0M | — | Filing → |